7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Join Veristat and nearly 2,500 professionals from biotech, pharma, finance and life sciences industry across Europe’s most innovative biopharma clusters at the Bio Europe Spring 2017 event.
![]()
March 20–22, 2017
CCIB Convention Centre, Barcelona, Spain
Veristat really enjoys helping small firms grow as they advance thier single product or even small pipeline of products through the clinical development and regulatory submission process. Consider meeting us at BioEurope Spring to discuss your current programs and tell us about the current challenges you are facing.
Learn how we've helped a current client as they grew not only thier company, but took thier product through the development process:
A Case Study | How Veristat Helps Growing Biotech Firms
A current client started working with Veristat over 6 years ago as a small venture funded biotech firm. Our initial engagement began with strategic consulting for their clinical development program and representation at numerous agency meetings (EMA & FDA), which has evolved over time to running over 15 studies. We helped them as they grew from a 4 person to a 300 person firm. Today, we remain a preferred provider and are working on thier submission for the original product that we helped them with.
To meet up with Veristat at this event, connect with us through the conference partnering system or fill out the form on the right side of this page.
We look forward to meeting you in Barcelona!
7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...